HNGE reports its first full quarterly earnings as a public company today with a clear tension: a stock up 12% over the past month, analysts broadly bullish, and yet shorts and insiders both adding to the pressure.
Short interest has climbed meaningfully ahead of the print, and the direction of that move is worth watching. At 11.8% of the free float, short interest is well into elevated territory — and it has risen roughly 14% over the past month, adding around 520,000 shares to the position. The borrow market, however, is not showing stress. Availability is extremely loose at 1,448%, meaning there are roughly fourteen shares available to lend for every one already borrowed, and the cost to borrow is just 0.55% — cheap even after rising 28% over the past week. That combination suggests shorts are building a considered position rather than scrambling for a crowded trade; the lending pool is accommodating them easily.
Options positioning tells a mildly more cautious story heading into the event. The put/call ratio is running slightly above its recent average at 0.52, roughly one standard deviation above the 20-day mean of 0.49. That is nowhere near the year's defensive extreme of 1.86, so options traders are not pricing in a panic — but there has been a clear drift toward more protective positioning over the past two weeks as the print approached.
The analyst community is firmly in the bull camp, and the most recent moves all point higher. Following the last earnings, a broad wave of firms — Canaccord, Stifel, RBC, Barclays, Wells Fargo, Needham — all raised price targets, with targets now ranging from $62 to $80. Canaccord nudged its target again to $65 just last week, keeping pace with the stock's move. The bull case centres on Hinge Health's position in the virtual physical therapy market: growing monthly active users, rising revenue guidance, and strategic employer partnerships that could drive durable subscription revenue. Bears push back on whether download and user-acquisition momentum actually converts into sticky long-term engagement, noting that digital health platforms often struggle to sustain utilisation beyond initial adoption — a concern made more pointed by the competitive dynamics in the space.
Insider activity adds a notable counterweight. Over the past week alone, the Founder and Executive Chairman Gabriel Mecklenburg has sold roughly $6.6 million in stock across multiple tranches. The CFO and President also sold shares on June 1. Over 90 days, net insider selling totals more than $61 million. Bessemer Venture Partners, a 10% owner, also sold $7.3 million across two dates in early June. Selling by VC backers following a recent IPO is common as lock-ups expire, and none of these transactions appear to reflect distressed exits — the prices achieved ranged from $56 to $66 — but the volume and breadth of selling is a signal the market will factor in alongside the headline numbers.
The print is therefore less a test of whether Hinge Health is growing and more a test of whether management can demonstrate that the engagement and monetisation metrics justify a stock trading at a P/E near 23x on a still-young public track record, against a backdrop of shorts building and insiders trimming.
See the live data behind this article on ORTEX.
Open HNGE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
